Tyson Foods (TSN) Highlights Growth Objectives at Barclays Conference
- BAT Reaches Deal to Acquire Reynolds American (RAI) for $49 Billion
- Morgan Stanley (MS) Tops Q4 EPS by 17c
- Trump, Brexit uncertainty hit stocks and dollar, gold jumps
- Noble Energy (NBL) to Acquire Clayton Williams Energy (CWEI) for $2.7B in Cash and Stock
- UnitedHealth Group (UNH) Tops Q4 EPS by 4c; Affirms Outlook
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Executives from Tyson Foods, Inc. (NYSE: TSN) told investors at the Barclays Global Consumer Staples Conference that the company is producing higher, more stable earnings and sales volume growth.
“As stated on our last earnings call, our adjusted earnings guidance for fiscal 2016 of $4.40-4.50 per share is 40 percent more than last year and represents a four-year compound annual growth rate of approximately 22 percent, and we’re confident we can achieve high single digit growth in fiscal 2017,” said Donnie Smith, Tyson Foods’ chief executive officer.
Tyson Foods is returning cash to shareholders through increasing dividends and share repurchases totaling 31 million shares in the previous 12 months through Aug. 8, Smith said. “Beyond dividends and share buybacks, we’ll use our substantial cash flows to invest in our business or make strategic acquisitions,” he said.
Tyson’s “Core 9” product lines, which feature the Tyson®, Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright®, Aidells® and State Fair® brands, are growing and gaining momentum, according to Tom Hayes, Tyson Foods’ president.
“The investments we made in the Core 9 to spur volume growth are generating returns,” he said. “We continue to outpace retail food and beverage. Tyson Core 9 is leading in volume performance among the top 10 consumer packaged goods retail food manufacturers, and Tyson Foods is one of only two companies to show growth in the latest quarter. We’re growing sales volume, sales dollar sales and market share,” Hayes said.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aqua America (WTR) Offers FY17 Guidance
- Pluristem Therapeutics (PSTI) Reports Clearance in Germany to Initiate Phase III Trial of PLX-PAD Cells in CLI
- Comerica (CMA) Tops Q4 EPS by 12c
Create E-mail Alert Related CategoriesCorporate News, Guidance, Management Comments
Related EntitiesBarclays, Dividend, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!